Tus kws kho mob
P20-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates — Effective June 6, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 1811 - 1820 ntawm 3562
Tus kws kho mob
P21-22 Medical Drug Management Update – Infliximab Prior Authorization and Preferred Product Expansion to Include Unbranded Infliximab
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P22-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P23-22 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P24-22 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
BCBSMN Provider Policy & Procedure Manual
Kev Cai Lij Choj thiab Kev Tswj Hwm
Authorization-for-Disclosure-of-Health-Information.pdf
Cov Txiaj Ntsig thiab Kev Duav Roos
Blue Plus Blue Advantage Provider and Pharmacy Directory